We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A randomised controlled trial of dexmedetomidine for delirium in adults undergoing heart valve surgery.
- Authors
Wang, H.‐B.; Jia, Y.; Zhang, C.‐B.; Zhang, L.; Li, Y.‐N.; Ding, J.; Wu, X.; Zhang, Z.; Wang, J.‐H.; Wang, Y.; Yan, F.‐X.; Yuan, S.; Sessler, D. I.
- Abstract
Summary: Dexmedetomidine might reduce delirium after cardiac surgery. We allocated 326 participants to an infusion of dexmedetomidine at a rate of 0.6 μg kg−1 for 10 min and then at 0.4 μg.kg−1.h−1 until the end of surgery; 326 control participants received comparable volumes of saline. We detected delirium in 98/652 (15%) participants during the first seven postoperative days: 47/326 after dexmedetomidine vs. 51/326 after placebo, p = 0.62, adjusted relative risk (95%CI) 0.86 (0.56–1.33), p = 0.51. Postoperative renal impairment (Kidney Disease Improving Global Outcomes stages 1, 2 and 3) was detected in 46, 9 and 2 participants after dexmedetomidine and 25, 7 and 4 control participants, p = 0.040. Intra‐operative dexmedetomidine infusion did not reduce the incidence of delirium after cardiac valve surgery but might impair renal function.
- Subjects
HEART valves; RANDOMIZED controlled trials; CARDIAC surgery; DEXMEDETOMIDINE; DELIRIUM
- Publication
Anaesthesia, 2023, Vol 78, Issue 5, p571
- ISSN
0003-2409
- Publication type
Article
- DOI
10.1111/anae.15983